208 related articles for article (PubMed ID: 33396536)
1. Antibacterial Activity of Fluorobenzoylthiosemicarbazides and Their Cyclic Analogues with 1,2,4-Triazole Scaffold.
Kosikowska U; Wujec M; Trotsko N; Płonka W; Paneth P; Paneth A
Molecules; 2020 Dec; 26(1):. PubMed ID: 33396536
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and antimicrobial activity of thiosemicarbazides, s-triazoles and their Mannich bases bearing 3-chlorophenyl moiety.
Plech T; Wujec M; Siwek A; Kosikowska U; Malm A
Eur J Med Chem; 2011 Jan; 46(1):241-8. PubMed ID: 21130541
[TBL] [Abstract][Full Text] [Related]
3. New thiophene-1,2,4-triazole-5(3)-ones: highly bioactive thiosemicarbazides, structures of Schiff bases and triazole-thiols.
Ünver Y; Sancak K; Çelik F; Birinci E; Küçük M; Soylu S; Burnaz NA
Eur J Med Chem; 2014 Sep; 84():639-50. PubMed ID: 25063946
[TBL] [Abstract][Full Text] [Related]
4. Synthesis of 1,2,3-triazole linked 4(3H)-Quinazolinones as potent antibacterial agents against multidrug-resistant Staphylococcus aureus.
Gatadi S; Gour J; Shukla M; Kaul G; Das S; Dasgupta A; Malasala S; Borra RS; Madhavi YV; Chopra S; Nanduri S
Eur J Med Chem; 2018 Sep; 157():1056-1067. PubMed ID: 30176536
[TBL] [Abstract][Full Text] [Related]
5. 1-(2-Hydroxybenzoyl)-thiosemicarbazides are promising antimicrobial agents targeting d-alanine-d-alanine ligase in bacterio.
Ameryckx A; Thabault L; Pochet L; Leimanis S; Poupaert JH; Wouters J; Joris B; Van Bambeke F; Frédérick R
Eur J Med Chem; 2018 Nov; 159():324-338. PubMed ID: 30300845
[TBL] [Abstract][Full Text] [Related]
6. Synergistic Effects of Thiosemicarbazides with Clinical Drugs against
Chudzik-Rząd B; Malm A; Trotsko N; Wujec M; Plech T; Paneth A
Molecules; 2020 May; 25(10):. PubMed ID: 32422899
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and structure-activity relationship studies of 4-arylthiosemicarbazides as topoisomerase IV inhibitors with Gram-positive antibacterial activity. Search for molecular basis of antibacterial activity of thiosemicarbazides.
Siwek A; Stączek P; Stefańska J
Eur J Med Chem; 2011 Nov; 46(11):5717-26. PubMed ID: 21978836
[TBL] [Abstract][Full Text] [Related]
8. The relationship between structure and in vitro antibacterial activity of selected isoflavones and their metabolites with special focus on antistaphylococcal effect of demethyltexasin.
Hummelova J; Rondevaldova J; Balastikova A; Lapcik O; Kokoska L
Lett Appl Microbiol; 2015 Mar; 60(3):242-7. PubMed ID: 25421722
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and in Vitro Antibacterial Evaluation of Novel 4-Substituted 1-Menthyl-1,2,3-triazoles.
Khaligh P; Salehi P; Bararjanian M; Aliahmadi A; Khavasi HR; Nejad-Ebrahimi S
Chem Pharm Bull (Tokyo); 2016; 64(11):1589-1596. PubMed ID: 27803470
[TBL] [Abstract][Full Text] [Related]
10. Structure-activity relationships of some 4-quinazolylthiosemicarbazides and their triazolo derivatives.
Jantová S; Hudecová D; Spirková K; Stankovský S
Folia Microbiol (Praha); 1994; 39(6):471-4. PubMed ID: 8549994
[TBL] [Abstract][Full Text] [Related]
11. The Antibacterial Activity of 1,2,3-triazole- and 1,2,4-Triazole-containing Hybrids against
Li J; Zhang J
Curr Top Med Chem; 2022; 22(1):41-63. PubMed ID: 34766892
[No Abstract] [Full Text] [Related]
12. Design, synthesis and biological evaluation of 4-benzoyl-1-dichlorobenzoylthiosemicarbazides as potent Gram-positive antibacterial agents.
Paneth A; Plech T; Kaproń B; Hagel D; Kosikowska U; Kuśmierz E; Dzitko K; Paneth P
J Enzyme Inhib Med Chem; 2016; 31(3):434-40. PubMed ID: 25897586
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis and antibacterial activities of 5-(pyrazin-2-yl)-4H-1,2,4-triazole-3-thiol derivatives containing Schiff base formation as FabH inhibitory.
Zhang F; Wen Q; Wang SF; Shahla Karim B; Yang YS; Liu JJ; Zhang WM; Zhu HL
Bioorg Med Chem Lett; 2014 Jan; 24(1):90-5. PubMed ID: 24332628
[TBL] [Abstract][Full Text] [Related]
14. A New 1,2,3-Triazole Scaffold with Improved Potency against
Stachura DL; Nguyen S; Polyak SW; Jovcevski B; Bruning JB; Abell AD
ACS Infect Dis; 2022 Dec; 8(12):2579-2585. PubMed ID: 36399035
[No Abstract] [Full Text] [Related]
15. Thiosemicarbazide Derivatives Decrease the ATPase Activity of
Kowalczyk A; Paneth A; Trojanowski D; Paneth P; Zakrzewska-Czerwińska J; Stączek P
Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33918623
[TBL] [Abstract][Full Text] [Related]
16. Efficient synthesis and antimicrobial activity of some novel S-β-d-glucosides of 5-aryl-1,2,4-triazole-3-thiones derivatives.
Ji D; Lu J; Lu B; Xin C; Mu J; Li J; Peng C; Bao X
Bioorg Med Chem Lett; 2013 Apr; 23(7):1997-2000. PubMed ID: 23466234
[TBL] [Abstract][Full Text] [Related]
17. Cleistochlamys kirkii chemical constituents: Antibacterial activity and synergistic effects against resistant Staphylococcus aureus strains.
Pereira F; Madureira AM; Sancha S; Mulhovo S; Luo X; Duarte A; Ferreira MJ
J Ethnopharmacol; 2016 Feb; 178():180-7. PubMed ID: 26674158
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis and antibacterial evaluation of novel 15-membered 11a-azahomoclarithromycin derivatives with the 1, 2, 3-triazole side chain.
Qin Y; Teng Y; Ma R; Bi F; Liu Z; Zhang P; Ma S
Eur J Med Chem; 2019 Oct; 180():321-339. PubMed ID: 31323617
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis, biological activities and DFT calculation of novel 1,2,4-triazole Schiff base derivatives.
Jin RY; Zeng CY; Liang XH; Sun XH; Liu YF; Wang YY; Zhou S
Bioorg Chem; 2018 Oct; 80():253-260. PubMed ID: 29966871
[TBL] [Abstract][Full Text] [Related]
20. 1,2,3-Triazole-containing hybrids with potential antibacterial activity against methicillin-resistant Staphylococcus aureus (MRSA).
Xu Z
Eur J Med Chem; 2020 Nov; 206():112686. PubMed ID: 32795773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
